EUFLEXXA is a viscoelastic solution designed for intra-articular injection. It is produced through bacterial fermentation using a saline medium devoid of animal-derived components. Sodium hyaluronate, the main ingredient, is a polysaccharide comprised of repeating disaccharide units of N-acetylglucosamine and sodium glucuronate linked by glycoside bonds beta-1,3 and beta-1,4.
The package includes:
- syringe (glass) with clamp luer-lock syringe with 2 ml single-use
- 1 box
Ingredients of the product:
- buffered saline (isotonic)
- viscoelastic, highly purified sodium hyaluronate
- high molecular weight of about 3 million Daltons (2.4 to 3.6 million Daltons)
The advantages of utilizing of EUFLEXXA:
- Recommended for addressing pain linked to knee osteoarthritis and other synovial joints
- Restores the viscoelastic attributes of synovial fluid
- Diminishes joint pain and dysfunction
- Enhances joint mobility and suppleness
What is the duration of the results?
For patients who exhibit a positive response to the treatment, the therapeutic effect lasts for a minimum of 26 weeks.